What You Should Know:
- NVIDIA and Massachusetts General Brigham Hospital
researchers develop an AI model that determines whether a person showing up in
the emergency room with COVID-19 symptoms will need supplemental oxygen hours
or even days after an initial exam.
- The ultimate goal of this model is to predict the
likelihood that a person showing up in the emergency room will need
supplemental oxygen, which can aid physicians in determining the appropriate
level of care for patients,
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Digital Behavioral Health: Addressing The COVID-19 Behavioral Health Crisis
Living through a pandemic is stressful and anxiety-inducing. Stay-at-home measures are compounding this stress, resulting in social isolation and unprecedented economic hardship, including mass layoffs and loss of health coverage. Fully understanding the impact of these pernicious trends on overall mental health will take time. However, precedents like the Great Recession suggest that these trends are likely to worsen the conditions driving suicide and substance-related deaths, the “deaths of
Read More
NIH Funds First Nationwide Rare and Atypical Diabetes Network
What You Should Know:
- NIH awards funding for Rare and Atypical Diabetes
Network, or RADIANT that will seek to discover the cause of
several unusual forms of diabetes.
- RADIANT plans to screen about 2,000 people with unknown
or atypical forms of diabetes that do not fit the common features of type 1 and
type 2 diabetes.
The National Institute of
Health (NIH), announced this week it is funding a nationwide study with The Rare and Atypical Diabetes
Network (RADIANT) that will seek
Read More
Nebula Gives Users Ownership Of Their Personal Genomic Data with Oasis Integration
What You Should Know:
- Nebula Genomics announces integration with Oasis Labs to give its customers full ownership and control of the data received from their comprehensive genome sequencing tests.
- Through Oasis Labs’ unique privacy solution Parcel, Nebula’s
users will be able to retain ownership and control of their personal genomic data.
Data remains confidential, and users can grant access to their data for
specific use cases such as generation of reports offered by Nebula or
Read More
NIH Taps PhysIQ to Develop AI-Based COVID-19 Digital Biomarker
What You Should Know:
- physIQ has been selected by the National Institute of Health (NIH) to develop an innovative AI-based COVID-19 digital biomarker solution to address the COVID-19 pandemic.
- Early detection of COVID-19 decompensation in patients
is complicated by infrequent and non-specific clinical data. The first-in-kind
tool will collect and analyzes continuous physiologic data could provide early
clinical indicators of COVID-19 decompensation.
The National Cancer
Institute
Read More
Amwell, Tyto Care Expand Partnership to Power Augmented Virtual Care Experiences
What You Should Know:
- Tyto
Care and Amwell® announced an expanded partnership, allowing
the companies to develop new integrations to enhance virtual care offerings for
providers.
- By pairing Tyto Care’s TytoHome device and platform
with Amwell’s platform, the two companies will together provide patients
and providers with augmented virtual care experiences and
broadly enrich the capabilities and satisfaction with healthcare organizations’
virtual
Read More
Anthem Expands Relationship with doc.ai to Power Digital Health Offerings
What You Should Know:
- Anthem extends the use of doc.ai's platform and portfolio of privacy-first technologies and artificial intelligence software services to drive the personalization of Anthem’s digital assets and create improved value for users.
- doc.ai’s product offerings are deployed on its cloud-agnostic and zero-trust infrastructure that lets clients like Anthem launch products faster and at lower costs.
Anthem, today announced it is extending its partnership with doc.ai,
Read More
UnitedHealth Acquires Online Pharmacy Startup DivvyDose
UnitedHealth
Group (UHG) has acquired
Illinois-based online pharmacy startup DivvyDose
for about $300M, according to sources familiar with the matter. Founded in 2015, divvyDOSE is a full-service personalized
pharmacy focused on those with multiple chronic conditions and complex
medication regimens. Customers receive a personalized roll of pre-sorted
medications into individual packs, with clearly marked dates and times.
Bloomberg first reported the acquisition discussions between UHG
Read More
Is Glucometrics The Missing Data in the Fight Against COVID-19?
Glucometrics – the system-wide analysis of inpatient glucose data – should be of fundamental interest for hospital administrators striving to improve the outcomes of their patients.
Why is this data so important? Proper glycemic control has been linked to improved outcomes and decreased length of stay time and time again across a myriad of conditions – whether it’s someone recuperating from a heart attack, battling pneumonia, or recovering from surgery.
The U.S. health system lacks
Read More
Vanderbilt University Medical Center to Create A Precision Medicine Trial Network Focused on Critical Illness
What You Should Know:
- Vanderbilt University Medical Center inks a strategic
partnership with Endpoint Health to create the world’s first precision medicine
trial network focused on critical illness.
- Late-stage interventional trials will evaluate
personalized approaches to existing care and novel targeted therapies.
Vanderbilt University
Medical Center (VUMC) and Endpoint
Health, the first targeted therapeutics company focused on integrated
solutions for critical illnesses, today
Read More
